Sepsis Diagnostics Segmentation
Product (Assay Kits & Reagents, Blood Culture Media)
The global market is segmented and analyzed for demand and supply by product into IBS with assay kits & reagents and blood culture media. Out of the two types of sepsis diagnostics, the blood culture media segment is estimated to gain the largest sepsis diagnostics market share of about 42% in the year 2037. The growth of the segment can be attributed to the increasing convenience and cost-effectiveness of this mode of testing. Further, the growing use of blood culture media by hospitals and pathology laboratories is also expected to contribute to the growth of the segment. For instance, it was found that the Sepifast system, which uses PCR techniques, had a better diagnostic performance when compared to blood cultures during an experimental study on patients from Thailand suffering from sepsis. As a result of increasing awareness about health care and the growing number of surgical procedures, it is also noted that instrument segments will continue to grow over the forecast period. For example, in September 2019 Guthrie, a U.S.-based Integrated Health System, started to use Wolters Kluwer Point of Care advisors for detecting and treating Sepsis at four hospitals within the area. All these factors are anticipated to contribute to the growth of the segment.
Technology (Microbiology, Immunoassays, Flow Cytometry)
The global sepsis diagnostics market is also segmented and analyzed for demand and supply by technology into microbiology, immunoassays, and flow cytometry. Amongst these three segments, the microbiology segment is expected to garner a significant share of around 45% in the year 2037. It is based on the fact that microbiological technology makes use of culture media tests to detect and identify sepsis organisms in a precise manner. Moreover, the growing segment is being driven by New Strategic Initiatives undertaken by major players. For instance, in April 2019, BD introduced the new BACTEC plasma quality monitoring media to help identify and reduce sepsis incidence among patients who receive blood transfusions. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Technology
|
|
|
By Pathogen |
|
|
By Testing Type |
|
